Autoantibodies and Autoantigens in Autoimmune Hepatitis

Christian P. Strassburg, MD, Michael P. Manns, MD

Semin Liver Dis. 2002;22(4)

Autoimmune Hepatitis Type 3

AIH type 3 is serologically defined by the presence of SLA/LP autoantibodies. However, 74% of patients also have other serological markers of autoimmunity, including SMA and AMA. AIH type 3 has a lower prevalence than AIH type 2 has, affects female patients in 90%, and has an age maximum between 20 and 40 years. This subclass of AIH is based solely on the autoantibody profile and clinically resembles AIH type 1.^[6]

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Next Section

Table 1. Table 1. Definitions of Antinuclear Antibodies and Their Relation to Primary Biliary Cirrhosis
PBC-specific ANA	Less PBC-specific ANA
Anti-gp210	Anti-cyclin A
Anti-nucleoporin p62	Anti-lamin B receptor
Anti-Sp100	Anti-promyelocytic leukemia protein

Table 1. Table 1. Definitions of Antinuclear Antibodies and Their Relation to Primary Biliary Cirrhosis
PBC-specific ANA	Less PBC-specific ANA
Anti-gp210	Anti-cyclin A
Anti-nucleoporin p62	Anti-lamin B receptor
Anti-Sp100	Anti-promyelocytic leukemia protein

Table 2. Table 2. Diagnosis Score for Autoimmune Hepatitis
Parameter	Score
Gender
Female	+2
Male	0
Serum biochemistry: ratio of elevation of serum alkaline phosphatase vs.aminotransferase
> 3.0	-2
1.5-3.0	0
< 1.5	+2
Total serum globulin, -globulin or IgG: times upper normal limit
> 2.0	+3
1.5-2.0	+2
1.0-1.5	+1
< 1.0	0
Autoantibodies (titers by immunfluorescence on rodent tissues): adults
ANA, SMA or LKM-1
> 1:80	+3
1:80	+2
1:40	+1
< 1:40	0
Antimitochondrial antibody
Positive	-4
Negative	0
Hepatitis viral markers
Negative	+3
Positive	-3
Other etiological factors
History of drug usage
Yes	-4
No	+1
Alcohol (average consumption)
< 25 g/d	+2
> 60 g/d	-2
Genetic factors: HLA DR3 or DR4	+1
Other autoimmune diseases	+2
Response to therapy
Complete	+2
Relapse	+3
Liver histology
Interface hepatitis	+3
Predominant lymphoplasacytic infiltrate	+1
Rosetting of liver cells	+1
None of the above	-5
Biliary changes	-3
Other changes	-3
Seropositivity for other defined autoantibodies	+2

Table 3. Table 3. Molecular Characterization of the Major Serological Marker Autoantibodies in Autoimmune Hepatitis
Antibody	kDa	Target Antigen	Disease
Autoantigens of the endoplasmic reticulum (microsomal autoantigens)
LKM-1	50	Cytochrome P450 2D6	Autoimmune hepatitis Type 2 hepatitis C
LKM-2	50	Cytochrome P450 2C9	Ticrynafen-induced hepatitis
LKM-3	55	UGTIA	Hepatitis D-associated autoimmunity
LKM	50	Cytochrome P450 2A6	Autoimmune hepatitis Type 2 Autoimmune polyendocrine syndrome type 1 (APS-1) Hepatitis C
LM	52	Cytochrome P450 1A2	Dihydralazine-induced hepatitis Hepatitis with autoimmune polyendocrine syndrome type 1 (APS-1)
	57	Disulfidisomerase	Halothane hepatitis
	59	Carboxylesterase	Halothane hepatitis
	35	?	Autoimmune hepatitis
	59	?	Chronic hepatitis C
	64	?	Autoimmune hepatitis
	70	?	Chronic hepatitis C
Soluble autoantigens of the cytoplasm
LC1	58-62	Formiminotransferase cyclodeaminase	Autoimmune hepatitis type 2 Autoimmune hepatitis Hepatitis C?
SLA/LP	50	UGA repressor tRNA-associated protein	Autoimmune hepatitis (type 3)

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

Return to Article

Post as:

processing....

Autoantibodies and Autoantigens in Autoimmune Hepatitis

Autoimmune Hepatitis Type 3

Comments

Most Popular Articles

About

Membership

Apps

WebMD Network

Editions

Autoantibodies and Autoantigens in Autoimmune Hepatitis

Autoimmune Hepatitis Type 3

Tables

Tables

Tables

Tables

References

Authors and Disclosures

Authors and Disclosures

Comments

Most Popular Articles

Email This

Feedback

Find Us On

About

Membership

Apps

WebMD Network

Editions